Search results
Results from the WOW.Com Content Network
Like many other medical conditions, obesity is the result of an interplay between environmental and genetic factors. [2] [3] Studies have identified variants in several genes that may contribute to weight gain and body fat distribution; although, only in a few cases are genes the primary cause of obesity.
Fat mass and obesity-associated protein also known as alpha-ketoglutarate-dependent dioxygenase FTO is an enzyme that in humans is encoded by the FTO gene located on chromosome 16. As one homolog in the AlkB family proteins, it is the first messenger RNA (mRNA) demethylase that has been identified. [ 5 ]
Using Kyte–Doolittle analysis, [25] the amino acid sequence of CD36 predicts a hydrophobic region near each end of the protein large enough to span cellular membranes.Based on this notion and the observation that CD36 is found on the surface of cells, CD36 is thought to have a 'hairpin-like' structure with α-helices at the C- and N- termini projecting through the membrane and a larger ...
A 2001 study of 13 people with a heterozygous frameshift mutation known as delta-G133 found that they had lower blood leptin levels than controls. There was an increased rate of obesity in these individuals, with 76% having a BMI of more than 30 compared to 26% in the control group. [89]
Monogenic obesity is excess weight caused by a mutation in a single gene, as opposed to syndromic obesity not tied to a single gene variation and most obesity, which is caused by multiple genetic and environmental risk factors. Monogenetic obesity mostly affects the hypothalamus and leptin–melanocortin system (see hypothalamic obesity ...
This represents the size of a composite genome based on data from multiple individuals but it is a good indication of the typical amount of DNA in a haploid set of chromosomes because the Y chromosome is quite small. [7] Most human cells are diploid so they contain twice as much DNA (~6.2 billion base pairs).
FFAR1 is highly expressed in pancreas beta cells which produce and release insulin into the blood; pancreas alpha cells which produce and release glucagon, a hormone that increases blood glucose levels; [9] enteroendocrine K, L, and I cells of the gastrointestinal tract which respectively produce and release glucagon-like peptide-1, gastric inhibitory peptide, and cholecystokinin which ...
Galectin-9, through its cytoplasmic action in control of AMPK, [11] [12] may affect various health conditions impacted by AMPK, including metabolism, obesity, diabetes, cancer, immune responses, and may be a part of the mechanism of action of the widely-prescribed anti-diabetes drug metformin.